Detecting flu at the doctor’s office | March 20, 2017 Issue - Vol. 95 Issue 12 | Chemical & Engineering News
Volume 95 Issue 12 | p. 7 | News of The Week
Issue Date: March 20, 2017

Detecting flu at the doctor’s office

Fast, inexpensive technique uses glucose meter to distinguish between bacterial and viral infections
Department: Science & Technology
News Channels: Biological SCENE, Analytical SCENE, Organic SCENE
Keywords: diagnostics, flu, influenze, neuraminidase, glucose meter, diagnosis
Viral neuraminidase enzyme cleaves galactose from a conjugate, and a glucose meter detects the liberated sugar.
Credit: of Medicine
Reaction scheme shows that viral surface neuraminidase cleaves galactose from a conjugate and that a glucose test strip and glucose meter then detect the liberated galactose.
Viral neuraminidase enzyme cleaves galactose from a conjugate, and a glucose meter detects the liberated sugar.
Credit: of Medicine

In doctor’s offices and emergency rooms, rapid flu tests can yield results in 15 minutes. These immunoassays, which use antibodies to detect influenza proteins, unfortunately produce false negatives in nearly half of flu cases. Polymerase chain reaction tests are more sensitive but often require experienced personnel, typically take hours or days to complete, and are expensive.

Researchers have now developed what could be a fast, accurate, and inexpensive alternative: an assay that uses a handheld glucose meter to detect flu virus (Chem. Sci. 2017, DOI: 10.1039/c6sc03720h).

In the assay, Suri S. Iyer of Georgia State University and coworkers treat nasal-swab samples with a synthetic conjugate of methoxylated sialic acid and galactose and apply the treated samples to glucose test strips. Neuraminidase enzyme on viruses in the samples cleaves galactose from the conjugate. This released galactose is oxidized by an enzyme on the test strip, producing a current that is measured by a glucose meter. The assay reliably detects viral infection or lack thereof in 15 minutes.

Bacteria also have neuraminidases, but those enzymes can’t recognize the conjugate. As a result, the assay distinguishes between bacteria and viruses.

Glucose meters have detected viruses before (Anal. Chem. 2012, DOI: 10.1021/ac203014s), but the conjugate is new. “The real breakthrough was finding a substrate that distinguishes between viral and bacterial neuraminidases,” says Amy Krafft, program officer for flu therapeutics and diagnostics development at the National Institute of Allergy & Infectious Diseases. The study “is a simple and clever proof of concept.”

Krafft thinks the researchers still need to assess the assay’s limits of detection and see if it can distinguish flu from other viruses. She also notes that it can’t distinguish type A from type B flu. Nevertheless, if Iyer and coworkers can optimize the test and turn it into a user-friendly kit, “it has a reasonable chance of becoming useful,” Krafft says.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society
Mark (March 20, 2017 10:24 PM)
It seems straight forward, but what are the biochemical interferrences and sample preparations that might be overlooked by nonprofessionals?

Leave A Comment

*Required to comment